Annual Meeting 2022: Natural Killer Cells and the Antitumor Immune Response
For the past several decades, researchers have been harnessing the power of the immune system to fight cancer. They...
Progress Against Cancer
For the past several decades, researchers have been harnessing the power of the immune system to fight cancer. They...
As outcomes improved for cancer patients in states that expanded Medicaid, disparities in survival disappeared.
Researchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
DNA sequencing found that in many cases when DCIS recurred, the lesion was unrelated to the first diagnosis, raising...
Testing for chromosomal abnormalities and gene mutations helps to direct treatment for patients with AML.
Different types of colorectal polyps can be difficult to distinguish, a new AI program improved pathologists’ accuracy in a...
Research suggests short bursts of intense calorie restriction could improve treatment response in patients with a range of cancers.
Success of immune checkpoint inhibitors in clinical trials does not always carry over to patients in the clinic.
Metastatic prostate cancer incidence rose after recommendation against routine screening, and FDA approves first PARP inhibitor for early-stage breast...
A new report from the American Association for Cancer Research explores how the COVID-19 pandemic affected cancer patients, researchers...